Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
University of Alabama at Birmingham
Mayo Clinic
Thomas Jefferson University